Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The review concluded that restrictions on people with HIV/AIDS often violated their rights without proven effectiveness in stopping the virus, highlighting education as the best control method.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

The rash resolved after stopping ponatinib.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The man likely has secondary syphilis affecting his nervous system.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

HIV-positive men who have sex with men have a higher rate of anal beta-papillomavirus infections.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Improved CRBN ligands make protein degraders more effective and drug-like.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Timely treatment with antibiotics and antiretrovirals can significantly improve health in HIV patients with syphilis.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.